Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 23

Results For "IMI"

5316 News Found

Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition
Drug Approval | June 22, 2026

Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition

Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility


Piramal Pharma Solutions achieves 200+ customer audits, 70 regulatory approvals in FY26
News | June 22, 2026

Piramal Pharma Solutions achieves 200+ customer audits, 70 regulatory approvals in FY26

CDMO strengthens global quality framework through digital transformation, AI-enabled investigations, workforce development and continuous audit readiness


Sun Pharma to acquire Innovcare Lifesciences for Rs. 271.2 crore
News | June 22, 2026

Sun Pharma to acquire Innovcare Lifesciences for Rs. 271.2 crore

Acquisition of Mumbai-based pharmaceutical, nutraceutical and cosmeceutical company expected to be completed by July 2026


LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy
News | June 21, 2026

LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy

The collaboration is focused on overcoming a major limitation in existing cancer drugs


Univar expands EMEA reach in botanical ingredients push with American Distilling partnership
Supply Chain | June 21, 2026

Univar expands EMEA reach in botanical ingredients push with American Distilling partnership

The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets


FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens
Drug Approval | June 21, 2026

FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens

The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections


Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3
Healthcare | June 20, 2026

Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3

Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge


Sameer Garaye promoted to Vice President at Hetero
People | June 20, 2026

Sameer Garaye promoted to Vice President at Hetero

Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities


Biopharma industry confidence reaches four-year high: GlobalData survey
Biopharma | June 19, 2026

Biopharma industry confidence reaches four-year high: GlobalData survey

Findings show growing optimism across the pharma sector as dealmaking accelerates, innovation strengthens, and companies adapt to tariffs, pricing reforms, and looming patent expirations


Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics
interviews | June 18, 2026

Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics

One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally